newsfilter
← Latest News
GlobeNewswire·

Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder

ADELAIDE, Australia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited ((ASX:BNO, NASDAQ:BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of